Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3))
Tadocizumab (Anti-Integrin a2b3 (ITGA2 & ITGB3)) is a humanized monoclonal antibody tageting integrin αIIbβ3. It has antiplatelet and antithrombotic effects, and can be used for cardiovascular disease research. MW :145.3 KD.
| Trivial name | C4G1; YM-337 |
| Catalog Number | A3065 |
| CAS# | 339086-80-5 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/tadocizumab-anti-integrin-a2b3-itga2---itgb3.html |